Chelombitko, M. A. http://orcid.org/0000-0002-3902-7812
Galkin, I. I. http://orcid.org/0000-0002-9025-3794
Pletjushkina, O. Yu. http://orcid.org/0000-0002-4963-9054
Zinovkin, R. A. http://orcid.org/0000-0001-5337-4346
Popova, E. N. http://orcid.org/0000-0002-7521-7736
Article History
Received: 21 June 2022
Revised: 25 July 2022
Accepted: 26 July 2022
First Online: 7 November 2022
COMPLIANCE WITH ETHICAL STANDARDS
: The authors declare that they have no conflicts of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.
: The work was performed on the EA.hy926 cell line, which is a hybrid primary culture of human umbilical vein endothelial cells (HUVEC) and A549 human lung tissue adenocarcinoma.
Free to read: This content has been made available to all.